Cargando…

Salvianolic Acid B Strikes Back: New Evidence in the Modulation of Expression and Activity of Matrix Metalloproteinase 9 in MDA-MB-231 Human Breast Cancer Cells

Salvianolic acid B (SalB) is a bioactive compound from Salviae miltiorrhizae, one of the most important traditional herbal medicines widely used in several countries for the treatment of cardiovascular diseases. The aim of this study was to evaluate the in vitro effect of SalB on the expression and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ianni, Andrea, Ruggeri, Pierdomenico, Bellio, Pierangelo, Martino, Francesco, Celenza, Giuseppe, Martino, Giuseppe, Franceschini, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740829/
https://www.ncbi.nlm.nih.gov/pubmed/36500603
http://dx.doi.org/10.3390/molecules27238514
_version_ 1784848163508584448
author Ianni, Andrea
Ruggeri, Pierdomenico
Bellio, Pierangelo
Martino, Francesco
Celenza, Giuseppe
Martino, Giuseppe
Franceschini, Nicola
author_facet Ianni, Andrea
Ruggeri, Pierdomenico
Bellio, Pierangelo
Martino, Francesco
Celenza, Giuseppe
Martino, Giuseppe
Franceschini, Nicola
author_sort Ianni, Andrea
collection PubMed
description Salvianolic acid B (SalB) is a bioactive compound from Salviae miltiorrhizae, one of the most important traditional herbal medicines widely used in several countries for the treatment of cardiovascular diseases. The aim of this study was to evaluate the in vitro effect of SalB on the expression and the activity of matrix metalloproteinase 9 (MMP-9), a zinc-dependent proteolytic enzyme, in human MDA-MB-231 breast cancer cells. This cellular model is characterized by a marked invasive phenotype, supported by a high constitutive expression of MMPs, especially gelatinases. SalB was first of all evaluated by in silico approaches primarily aimed at predicting the main pharmacokinetic parameters. The most favorable interaction between the natural compound and MMP-9 was instead tested by molecular docking analysis that was subsequently verified by an enzymatic inhibition assay. MDA-MB-231 cells were treated with SalB 5 µM and 50 µM for 24 h and 48 h. The conditioned media obtained from treated cells were then analyzed by gelatin zymography and reverse zymography to, respectively, evaluate the MMP-9 activity and the presence of TIMP-1. The expression of the enzyme was then evaluated by Western blot on conditioned media and by analysis of transcripts through reverse transcriptase-polymerase chain reaction (RT-PCR). The in silico approach showed the ability of SalB to interact with the catalytic zinc ion of the enzyme, with a plausible competitive mode of action. The analysis of conditioned culture media showed a reduction in MMP-9 activity and the concomitant decrease in the enzyme concentration, partially confirmed by analysis of transcripts. SalB showed the ability to modulate the function of MMP-9 in MDA-MB-231 cells. To our knowledge, this is the first time in which the role of SalB on MMP-9 in a highly invasive cellular model is investigated. The obtained results impose further and more specific evaluations in order to obtain a better understanding of the biochemical mechanisms that regulate the interaction between this natural compound and the MMP-9.
format Online
Article
Text
id pubmed-9740829
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97408292022-12-11 Salvianolic Acid B Strikes Back: New Evidence in the Modulation of Expression and Activity of Matrix Metalloproteinase 9 in MDA-MB-231 Human Breast Cancer Cells Ianni, Andrea Ruggeri, Pierdomenico Bellio, Pierangelo Martino, Francesco Celenza, Giuseppe Martino, Giuseppe Franceschini, Nicola Molecules Article Salvianolic acid B (SalB) is a bioactive compound from Salviae miltiorrhizae, one of the most important traditional herbal medicines widely used in several countries for the treatment of cardiovascular diseases. The aim of this study was to evaluate the in vitro effect of SalB on the expression and the activity of matrix metalloproteinase 9 (MMP-9), a zinc-dependent proteolytic enzyme, in human MDA-MB-231 breast cancer cells. This cellular model is characterized by a marked invasive phenotype, supported by a high constitutive expression of MMPs, especially gelatinases. SalB was first of all evaluated by in silico approaches primarily aimed at predicting the main pharmacokinetic parameters. The most favorable interaction between the natural compound and MMP-9 was instead tested by molecular docking analysis that was subsequently verified by an enzymatic inhibition assay. MDA-MB-231 cells were treated with SalB 5 µM and 50 µM for 24 h and 48 h. The conditioned media obtained from treated cells were then analyzed by gelatin zymography and reverse zymography to, respectively, evaluate the MMP-9 activity and the presence of TIMP-1. The expression of the enzyme was then evaluated by Western blot on conditioned media and by analysis of transcripts through reverse transcriptase-polymerase chain reaction (RT-PCR). The in silico approach showed the ability of SalB to interact with the catalytic zinc ion of the enzyme, with a plausible competitive mode of action. The analysis of conditioned culture media showed a reduction in MMP-9 activity and the concomitant decrease in the enzyme concentration, partially confirmed by analysis of transcripts. SalB showed the ability to modulate the function of MMP-9 in MDA-MB-231 cells. To our knowledge, this is the first time in which the role of SalB on MMP-9 in a highly invasive cellular model is investigated. The obtained results impose further and more specific evaluations in order to obtain a better understanding of the biochemical mechanisms that regulate the interaction between this natural compound and the MMP-9. MDPI 2022-12-03 /pmc/articles/PMC9740829/ /pubmed/36500603 http://dx.doi.org/10.3390/molecules27238514 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ianni, Andrea
Ruggeri, Pierdomenico
Bellio, Pierangelo
Martino, Francesco
Celenza, Giuseppe
Martino, Giuseppe
Franceschini, Nicola
Salvianolic Acid B Strikes Back: New Evidence in the Modulation of Expression and Activity of Matrix Metalloproteinase 9 in MDA-MB-231 Human Breast Cancer Cells
title Salvianolic Acid B Strikes Back: New Evidence in the Modulation of Expression and Activity of Matrix Metalloproteinase 9 in MDA-MB-231 Human Breast Cancer Cells
title_full Salvianolic Acid B Strikes Back: New Evidence in the Modulation of Expression and Activity of Matrix Metalloproteinase 9 in MDA-MB-231 Human Breast Cancer Cells
title_fullStr Salvianolic Acid B Strikes Back: New Evidence in the Modulation of Expression and Activity of Matrix Metalloproteinase 9 in MDA-MB-231 Human Breast Cancer Cells
title_full_unstemmed Salvianolic Acid B Strikes Back: New Evidence in the Modulation of Expression and Activity of Matrix Metalloproteinase 9 in MDA-MB-231 Human Breast Cancer Cells
title_short Salvianolic Acid B Strikes Back: New Evidence in the Modulation of Expression and Activity of Matrix Metalloproteinase 9 in MDA-MB-231 Human Breast Cancer Cells
title_sort salvianolic acid b strikes back: new evidence in the modulation of expression and activity of matrix metalloproteinase 9 in mda-mb-231 human breast cancer cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740829/
https://www.ncbi.nlm.nih.gov/pubmed/36500603
http://dx.doi.org/10.3390/molecules27238514
work_keys_str_mv AT ianniandrea salvianolicacidbstrikesbacknewevidenceinthemodulationofexpressionandactivityofmatrixmetalloproteinase9inmdamb231humanbreastcancercells
AT ruggeripierdomenico salvianolicacidbstrikesbacknewevidenceinthemodulationofexpressionandactivityofmatrixmetalloproteinase9inmdamb231humanbreastcancercells
AT belliopierangelo salvianolicacidbstrikesbacknewevidenceinthemodulationofexpressionandactivityofmatrixmetalloproteinase9inmdamb231humanbreastcancercells
AT martinofrancesco salvianolicacidbstrikesbacknewevidenceinthemodulationofexpressionandactivityofmatrixmetalloproteinase9inmdamb231humanbreastcancercells
AT celenzagiuseppe salvianolicacidbstrikesbacknewevidenceinthemodulationofexpressionandactivityofmatrixmetalloproteinase9inmdamb231humanbreastcancercells
AT martinogiuseppe salvianolicacidbstrikesbacknewevidenceinthemodulationofexpressionandactivityofmatrixmetalloproteinase9inmdamb231humanbreastcancercells
AT franceschininicola salvianolicacidbstrikesbacknewevidenceinthemodulationofexpressionandactivityofmatrixmetalloproteinase9inmdamb231humanbreastcancercells